Undoubtedly, HKL treatment elevated neuronal SIRT3 protein, increased mitochondrial LC3II/LC3I, Parkin, and PINK1 proteins, and decreased mitochondrial P62 protein in the hippocampal neuronal model of AD (p < 0.01). The gene discussed is PRKN; the disease is Alzheimer disease.